Dupilumab as treatment for atopic dermatitis in a pediatric heart transplant patient: A case report
- PMID: 32672892
- DOI: 10.1111/dth.14018
Dupilumab as treatment for atopic dermatitis in a pediatric heart transplant patient: A case report
References
REFERENCES
-
- Ramirez FD, Chen S, Langan SM, et al. Association of atopic dermatitis with sleep quality in children. JAMA Pediatr. 2019;173(5):e190025. https://doi.org/10.1001/jamapediatrics.2019.0025.
-
- Marcus N, Amir AZ, Grunebaum E, et al. De novo allergy and immune-mediated disorders following solid-organ transplantation: prevalence, natural history, and risk factors. J Pediatr. 2018;196:154-160.e2. https://doi.org/10.1016/j.jpeds.2017.11.026.
-
- Weimer R, Melk A, Daniel V, Friemann S, Padberg W, Opelz G. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. Hum Immunol. 2000;61(9):884-897. https://doi.org/10.1016/S0198-8859(00)00152-X.
-
- López-Abente J, Bernaldo-de-Quirós E, Camino M, et al. Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart-transplant children: a delicate balance between risk of rejection or atopic symptoms. Am J Transplant. 2019;19(5):1536-1544. https://doi.org/10.1111/ajt.15245.
-
- Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130-139. https://doi.org/10.1056/NEJMoa1314768.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
